Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids

Erstveröffentlichung

2008

Authors

Kirchheiner, Julia

Meineke, Ingolf

Fuhr, Uwe

Rodriguez-Antona, Cristina

Lebedeva, Elena

et al.

Wissenschaftlicher Artikel

Published in

Pharmacogenomics ; 9 (2008), 3. - S. 277-288. - ISSN 1462-2416. - eISSN 1744-8042

Link to publication

https://dx.doi.org/10.2217/14622416.9.3.277

Institutions

UKU. Institut für Naturheilkunde und Klinische Pharmakologie

Subject headings

[Free subject headings]: CYP2C8 | cycochrome P450 | eicosanoids | epoxyeicosatetraenoic acid | SOLUBLE EPOXIDE HYDROLASE | CYTOCHROME-P450 EPOXYGENASE CYP2J2 | CORONARY-ARTERY-DISEASE | EPOXYEICOSATRIENOIC ACIDS | ARACHIDONIC-ACID | MYOCARDIAL-INFARCTION | ATHEROSCLEROSIS RISK | HEART-DISEASE | PHARMACOKINETICS | METABOLISM
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record